Current tendering process for public procurement of pharmaceuticals in Indonesia affecting UK exports
Trade barrier summary
In Indonesia, the current bidding system for public contracts makes it difficult to add medicines to the market. It has become increasingly difficult to list new medicines in Indonesia’s National Formulary, in which listing decisions appear to be primarily based on price and the overall BPJS budget. This is a significant barrier to trade since it is not consistent with international guidelines that state that listing decisions should reflect multiple sources of evidence, which include scientific data demonstrating drug safety and efficacy.
Sectors affected
- Pharmaceuticals and biotechnology
Resolved
No
Date reported
14 September 2020
Last updated
17 December 2020
Public ID
PID-6947R9
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.